BaseLaunch in Basel supports biotech and healthtech ventures in person, offering up to CHF 500,000 in financing alongside access to partners, global biopharma investors and laboratory infrastructure where needed. No equity or convertible terms are published, and no programme length is stated; applications run through a two-step process beginning with an expression of interest.
Investment
CHF 500,000 (Above Europe & C. Asia median $54.5k · Above global median $61.3k)